VEGF mRNA is Stabilized by Ras and Tyrosine Kinase Oncogenes, as well as by UV Radiation—Evidence for Divergent Stabilization Pathways

Growth Factors

Volumn 14, Issue 42038, 1997, Pages 199-212

  White, F C ^a   Benehacene, A ^a   Scheele, J S ^a   Kamps, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

farnesyl transferase competitor; genistein; hypoxia; oncogenes; signal transduction; VEGF

Indexed keywords

CYSTEINE DERIVATIVE; GENISTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; VASCULARIZATION;

3T3 CELLS; ACETYLCYSTEINE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL HYPOXIA; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENES, RAS; GENISTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISOFLAVONES; LYMPHOKINES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RAS PROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0030738878     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977199709021520     Document Type: Article

References (59)

1. Azuma A., Onishi Y., Sato Y., Kizaki H. Affects of protein kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2–dependent CTLL-2 cells. J. Biochemistry 1995; 118: 312 – 318
2. Barbacid M. ras Genes. Ann. Rev. Biochem 1987; 56: 779 – 827
3. Belasco J., Brawerman G. Control of Messenger R NA Stability. Academic Press, Inc., San Diego 1993; 3 – 495
4. Berkman R. A., Merrill M. J., Reinhold W. C., Monacci W. T., Saxena A., Clark W. C., Robertson J. T., Ali T. U., Oldfield E. H. Expression of the vascular permeability factor/ vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest 1993; 91: 153 – 159
5. Berse B., Brown L. F., Van de Water L., Dvorak H. F., Senger D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 1992; 3: 211 – 220
6. Bonnieu A., Piechaczyk M., Marty L., Cuny M., Blanchad J.-M., Fort P., Jeanteur P. Sequence Determinants of c-myc mRNA Turn-over: Influence of 3′ and 5′ Non-coding Regions. Oncogene Research 1998; 3: 155 – 166
7. Brown L. F., Berse B., Jackman R. W., Tognazzi K., Manseau E. J., Dvorak H. F., Senger D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol 1993a; 143: 1255 – 1262
8. Brown L. F., Berse B., Jackman R. W., Tognazzi K., Manseau E. L., Senger D. R., Dvorak H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Research 1993b; 53: 4727 – 4735
9. Brown L. F., Berse B., Jackman R. W., Tognazzi K., Guidi A. J., Dvorak H. F., Sengcr D. R., Connolly J. L., Schnitt S. J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology 1995; 26: 86 – 91
10. Bruce J. N., Criscuolo G. R., Menill M. J., Moquin R. R., Blacklock J. B., Oldfield E. H. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexam-ethasone. J. Neurosurg 1987; 67: 88 – 884
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 1987; 162: 156 – 159
12. De Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989 – 991
13. Devary Y., Gottlieb R. A., Smeal T., Karin M. The mammalian Ultraviolet Response is triggered by activation of Src Tyrosine Kinases. Cell 1992; 71: 1081 – 1091
14. Dvorak H. F., Orenstein N. S., Carvalho A. C., Churchill W. H., Dvorak A. M., Gaili S. J., Feder J., Bitzer A. M., Rypysc J., Giovinco P. Induction of a fibrin-gel investment: an early event in line 10 hepatocareinoma growth mediated by tumor-secreted products. J. Immunol 1979; 122: 166 – 174
15. Dvorak H. F., Sioussat T. M., Brown L. F., Berse B., Nagy J. A., Sotrel A., Manseau E. J., Van de Water L., Senger D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J. Exp. Med 1991; 174: 1275 – 1278
16. Ebert M., Yokohama M., Friess H., Kobrin M. S., Buchler M. W., Korc M. Induction of platelet-derived growth factor A and B chains and over expression of their receptors in human pancreatic cancer. Int. J. Cancer 1995; 62: 529 – 535
17. Engelberg D., Klein C., Martinetto H., Struhl K., Karin M. The UV response involving the Ras signaling pathway and Ap-1 transcription factors is conserved between yeast and mammals. Cell 1994; 77: 381 – 390
18. Ferrara N., Henzel W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelid cells. Biochem. Biophys. Res Commun 1989; 161: 851 – 858
19. Ferrara N., Houck K., Jakeman L., Leung D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev 1992; 13: 18 – 32
20. Finkenzeller G., Marme D., Weich H. A., Hug H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C(1). Cancer Res 1992; 52: 4821 – 4823
21. Folkman J. What is the evidence that tumors are angiogenesis dependent? [editorial]. J Natl. Cancer Inst 1990; 82: 4 – 6
22. Fritz G., Kaina B., Aktories K. The ras related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. Journal of Biological Chemistry 1995; 270: 25172 – 25177
23. Ganido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granuloma cells. Growth Factors 1993; 8: 109 – 117
24. Gibbs J. B., Oliff A., Kohl N. Farnesyltransferase Inhibitors: Ras Research Yields a Potential Cancer Therapeutic. Cell 1994; 77: 175 – 178
25. Gitay-Goren H., Halaban R., Neufeld G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun 1993; 190: 702 – 708
26. Goldberg M. A., Schneider T. J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem 1994; 269: 4355 – 4359
27. Grugel S., Finkenzeller G., Weindel K., Barleon B., Marme D. Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH3T3 Cells. J. Biol. Chem 1995; 270: 25915 – 25919
28. Harold S., Genovese C., Kobrin B., Morrison S. L., Milcarek C. A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of tran-scriptional inhibitors. Anal. Biochem 1991; 198: 19 – 29
29. Huang W., Erikson R. L. Constitutive activation of Mekl by mutation of serine phosphorylation sites. Proc. Natl. Acad. Sci. U.S.A 1994; 91: 8960 – 8963
30. Hung M.-C., Matin A, Zhang Y., Xing X, Sorgi F., Huang L., Yu D. HER-2 /mu-targeting gene therapy-a review. Gene 1995; 159: 65 – 71
31. Kamps M. P., Mum C., Sun X.-H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in Pre-B All. Cell 1990; 60: 547 – 555
32. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309 – 1312
33. Levy A. P., Levy N. S., Wergner S., Goldberg M. A. Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia. J. Biol. Chem 1995; 270: 13333 – 13340
34. Levy A. P., Levy N. S., Goldberg M. A. Post-transcrip-tional Regulation of Vascular Endothelial Growth Factor by Hypoxia. J. Biol. Chem 1996; 271: 2746 – 2753
35. Li Y., Lieherman M. W. Two genes associated with liver cancer are regulated by different mechanisms in raq T24 transformed liver epithelial cells. Oncogene 1989; 4: 795 – 798
36. Lindmark J., Sunberg C, Glimelius B., Pahlman L., Rubin K., Gerdin B. Stromal expression of platelet derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab. Invest 1993; 69: 682 – 689
37. Liu Y., Cox S. R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res 1995a; 77: 638 – 643
38. Liu Y., Cox S. R., Morita T., Kouremhanas S. Hypoxia Regulatm Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells. Circ. Res 1995b; 77: 638 – 643
39. Lobb R. R., Key M. E., Alderman E. M., Fett J. W. Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line. Int. J. Cancer 1985; 36: 473 – 478
40. Marom M., Haklai R., Ben-Baruch G., Marciano D., Egozi Y., Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J. Biol. Chem. 1995; 270: 22263 – 22270
41. Mukhopadhyay D., Tsiokas L., Zhou X.-M., Foster D., Brugge J. S., Sukhatme V. P. Hypoxic Induction of Human Vascular Endothelial Growth Factor Expression through c-Src activation. Nature 1995; 375: 577 – 581
42. Nagasu T., Yoshimatsu K., Rowell C., Lewis M. D., Garcia A. M. Inhibition of Human Tumor Xenograft Growth by treatment with the farnesyl transferase inhibitor B956. Cancer Research 1995; 55: 5310 – 5314
43. Nagy J., Clark J. S., Cooke A., Campbell A. M., Conor J. M., Purushotham A. D., George W. D. Expression and loss of heterozygosity of c-met proto oncogene in primary breast cancer. J. of Surg. Onco. 1995; 60: 95 – 99
44. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845 – 848
45. Rak J., Mitsuhashi Y., Bayko L., Filnius J., Shirasawa S., Sasazuki T., Kerhel R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Research 1995; 55: 4575 – 4580
46. Renshaw M. W., Kipreos K., Albrecht M. R., Wang Y. J. Oncogenic v-Abl tyrosine Kinase Can Inhibit or Stimulate Growth, Depending on Cell Context. EMBO J 1992; 11: 3941 – 3951
47. Risau W. Angiogenic growth factors. Prog. Grwth. Fact. Res 1990; 2: 71 – 79
48. Semenza G. L., Roth P. H., Fang H. M., Wang G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 1994; 269: 23757 – 23763
49. Senger D. R., Penuzzi C. A., Feder J., Dvorak H. F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629 – 5632
50. Shaw G., Kamen R. A Conserved AU sequence from the 3′ Untranslated Region of GM-CSF mRNA Mediates Selective mRNA Degradation. Cell 1986; 46: 659 – 667
51. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843 – 845
52. Shyu A.-B., Greenberg M. E., Belasco J. G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev 1989; 3: 60 – 72
53. Slack J. L., Parker M. I., Robinson V. R., Bomstein P. Regulation of Collagen I gene expression by ras. Mol. Cell Biol 1992; 12: 4714 – 4723
54. Stein I., Neeman M., Shweliki D., Itin A., Keshet E. Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia and Hypoglycemia and Coregulation with other Ischemia-Induced Genes. Mol. Cell Biol 1995; 15: 5363 – 5368
55. Takahashi M. Oncogenic activation of the ret protooncogene in thyroid cancer. Critical Reviews in Oncogenesis 1995; 6: 3546
56. Thomas S. M., DeMarco M., D'Arcangelo G., Halegouaand S., Brugge J. S. Ras is essential for nerve growth factor and phorhol ester-induced tyrosine phospho Iylation of MAP kinases. Cell 1992; 68: 1031 – 1040
57. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., Abraham J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem 1991; 266: 11947 – 11954
58. Wang G. L., Semenza G. L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. U.S.A 1993; 90: 4304 – 4308
59. White F. C., Carroll S. C., Kamps M. P. VEGF mRNA is Reversibly stabilized by Hypoxia and Persistently Stabilized in VEGF-Overexpressing Human Tumor Cell Lines. Growth Factors 1995; 12: 289 – 301